World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
88
Citations
28806
World Ranking
13149
National Ranking
185

Albert Parés publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Albert Parés sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 458 publications — 50th percentile

50% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Albert Parés D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Albert Parés sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 88 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Albert Parés is affiliated with the University of Barcelona in Spain and has an extensive research portfolio in the field of medicine, with a focus on hepatology. Their work is primarily centered on liver diseases and related immunological responses, treatment methodologies, and diagnostic strategies. Parés' academic contributions span multiple subfields including hepatology, epidemiology, surgery, pulmonary and respiratory medicine, and oncology.

Their main research topics include:

  • Liver Diseases and Immunity
  • Liver Disease Diagnosis and Treatment
  • Pediatric Hepatobiliary Diseases and Treatments
  • Gallbladder and Bile Duct Disorders
  • Drug Transport and Resistance Mechanisms
  • Liver Disease and Transplantation
  • Hepatitis B Virus Studies

Albert Parés has published frequently in several scientific journals, contributing to the body of knowledge in hepatology and related fields. The main publication venues where their work appears are:

  • Journal of Hepatology
  • JHEP Reports
  • The American Journal of Gastroenterology
  • Liver International
  • Gastroenterology

Among their recent notable papers are:

  • Fibrates for Itch (FITCH) in Fibrosing Cholangiopathies: A Double-Blind, Randomized, Placebo-Controlled Trial (2020, Gastroenterology)
  • A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCA (2021, Journal of Hepatology)
  • Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase (2020, The American Journal of Gastroenterology)
  • Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group (2022, Journal of Hepatology)
  • A placebo-controlled randomised trial of budesonide for PBC following an insufficient response to UDCA (2020, Journal of Hepatology)

Collaboration forms a significant aspect of Parés' work, evidenced by frequent co-authors contributing substantially to their research output. Key collaborators include:

  • Gideon M. Hirschfield
  • Annarosa Floreani
  • Pietro Invernizzi
  • Christophe Corpechot
  • Douglas Thorburn

Best Publications

  • Simplified criteria for the diagnosis of autoimmune hepatitis

    Elke M. Hennes;Mikio Zeniya;Albert. J. Czaja;Albert Parés

  • EASL Clinical Practice Guidelines: management of cholestatic liver diseases

    Ulrich Beuers;Kirsten M. Boberg;Roger W. Chapman;Olivier Chazouillères

  • EASL Clinical Practice Guidelines on nutrition in chronic liver disease

    Manuela Merli;Annalisa Berzigotti;Shira Zelber-Sagi;Srinivasan Dasarathy

  • Excellent Long-Term Survival in Patients With Primary Biliary Cirrhosis and Biochemical Response to Ursodeoxycholic Acid

    Albert Parés;Llorenç Caballería;Juan Rodés

  • S-Adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial

    Jose M Mato;Javier Cámara;Javier Fernández de Paz;Llorenç Caballería

  • Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid

    Gideon M. Hirschfield;Andrew Mason;Velimir Luketic;Velimir Luketic;Keith Lindor;Keith Lindor

  • Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial

    Rafael Bañares;Rafael Bañares;Frederik Nevens;Fin Stolze Larsen;Rajiv Jalan

  • Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: An international follow-up study

    Willem J. Lammers;Henk R. van Buuren;Gideon M. Hirschfield;Harry L.A. Janssen

  • Changing nomenclature for PBC: from ‘cirrhosis’ to ‘cholangitis’

    Ulrich H W Beuers;M Eric Gershwin;Robert G Gish;Pietro Luigi Invernizzi

  • Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial

    Albert Parés;Ramón Planas;Miguel Torres;Joan Caballería

  • Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis

    Tobias J. Weismüller;Tobias J. Weismüller;Palak J. Trivedi;Annika Bergquist;Mohamad Imam;Mohamad Imam

  • Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy

    Willem J. Lammers;Gideon M. Hirschfield;Christophe Corpechot;Frederik Nevens

  • Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial.

    Eduard Cabré;Pilar Rodríguez-Iglesias;Joan Caballería;Joan C. Quer

  • Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis

    Jimmy Z Liu;Johannes Roksund Hov;Trine Folseraas;Trine Folseraas;Eva Ellinghaus

  • Histological course of alcoholic hepatitis: Influence of abstinence, sex and extent of hepatic damage

    Albert Parés;Joan Caballería;Miquel Bruguera;Miquel Torres

  • Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial

    Albert Parés;Llorenç Caballería;Juan Rodés;Miquel Bruguera

  • Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation.

    K. M. Boberg;A. Bergquist;S. Mitchell;A. Pares

  • Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease

    Sun Gou Ji;Brian D. Juran;Sören Mucha;Trine Folseraas

  • Hepatitis C virus antibodies in chronic alcoholic patients: association with severity of liver injury.

    Albert Parés;Josep María Barrera;Joan Caballería;Guadalupe Ercilla

  • Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis

    Jimmy Z. Liu;Johannes Roksund Hov;Trine Folseraas;Eva Ellinghaus

Frequent Co-Authors

Gideon M. Hirschfield
Gideon M. Hirschfield University Health Network
Juan Rodés
Juan Rodés University of Barcelona
Bettina E. Hansen
Bettina E. Hansen University Health Network
Keith D. Lindor
Keith D. Lindor Arizona State University
Cyriel Y. Ponsioen
Cyriel Y. Ponsioen University of Amsterdam
Kris V. Kowdley
Kris V. Kowdley Washington State University
Harry L.A. Janssen
Harry L.A. Janssen Erasmus University Rotterdam
Kirsten Muri Boberg
Kirsten Muri Boberg University of Oslo
Roger W. Chapman
Roger W. Chapman University of Oxford

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative healthcare pathways can open doors to diverse career options within medicine. For those seeking a faster entry point into the healthcare workforce, 6 month lpn program options offer accelerated training to become a Licensed Practical Nurse. This route is ideal for students looking to start working and gaining hands-on experience quickly.

If you're interested in advanced practice roles, there are multiple online options available. Aspiring psychiatric nurse practitioners can consider enrolling in psych np online programs. These programs combine flexibility with in-depth psychiatric and mental health expertise, preparing graduates for high-demand clinical positions.

For those drawn to the administrative side of healthcare, a variety of online degrees offer affordable entry points. Pursuing the cheapest online health science degree helps students save on tuition while building a strong foundation in health systems and policy. For career advancement, consider the cheapest online mha programs, which prepare graduates for leadership roles in hospitals, clinics, and public health organizations.

Best Scientists Citing Albert Parés

Trending Scientists

Recently Published Articles